The $2.6 Billion Pill--Methodologic and Policy Considerations

N Engl J Med. 2015 May 14;372(20):1877-9. doi: 10.1056/NEJMp1500848.

MeSH terms

  • Capital Expenditures / statistics & numerical data
  • Drug Approval / economics
  • Drug Costs*
  • Drug Discovery / economics*
  • Drug Industry / economics*
  • Financing, Government*
  • National Institutes of Health (U.S.)
  • Research Support as Topic / statistics & numerical data
  • United States